Ability to tailor diagnostics, therapeutics to specific patients is key to precision medicine Global precision oncology market projected to grow at CAGR of 9.9% over the next eight years, will reach $99.7 billion by 2027 Varian Bio making significant headway in development of two preclinical experimental cancer drugs Healthtech Solutions (OTC: HLTT) is making a strong […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.